To be moved by Councillor Yasseen and seconded by Councillor Bower.
Minutes:
An amendment to the
original motion was accepted by the mover and seconder of the
original Motion and, therefore, in accordance with Procedure Rule
18(14) the amendment was incorporated into the Motion for debate
(inclusions highlighted in bold italics).
The original motion
was moved by Councillor Yasseen and seconded by Councillor Bower.
The amendment was moved by Councillor Read and seconded by
Councillor Garnett. The substantive motion was:
That this Council:
Notes that:
1.
In November 2023, NHS England awarded a seven year contract worth
up to £330 million to Palantir Technologies to provide the
NHS Federated Data Platform. The platform brings together
information already held in different NHS systems to support
patient care, hospital management, waiting-list planning and wider
NHS decision making.
2.
Palantir is a foreign (US based) private software and data
analytics company with extensive involvement in military,
intelligence, surveillance and immigration enforcement
systems.
3.
The Federated Data Platform infrastructure can access and process
identifiable and highly sensitive patient information. Therefore
raising legitimate questions about which companies should be
trusted to operate essential NHS data infrastructure, what access
their personnel may require and how that access is independently
monitored.
4.
The information people share with their GP, hospital and other
health services may include diagnoses, medication, mental health,
disability, sexual and reproductive health, family circumstances
and other deeply personal information. Residents should not need to
understand a complex technology contract to know who is handling
this information and why.
5.
Palantir has supplied technology to US Immigration and Customs
Enforcement for immigration surveillance and enforcement
operations. In January 2024, Palantir also announced a strategic
partnership with the Israeli Ministry of Defence to provide
technology in support of “war related missions”. These
activities have resulted in serious ethical and human rights
concerns about the company.
6.
The British Medical Association (BMA) has passed a resolution
declaring Palantir an unacceptable partner for the NHS Federated
Data Platform. The resolution calls for an end to Palantir’s
continued expansion within the NHS, the termination of existing NHS
contracts with Palantir and to support doctors who refuse to use
data products supplied by companies associated with warfare and
human rights violations.
7.
Medact, Amnesty International and patient and health worker
organisations have also raised concerns about human rights,
transparency, public trust, procurement, privacy and long term
dependence on a single supplier.
8.
On 3 June 2026, the cross-party House of Commons Science,
Innovation and Technology Committee recommended that the Government
exercise the February 2027 break clause in the Palantir contract.
It called for either an NHS developed replacement or an alternative
supplied by UK owned and UK based providers, together with a costed
exit plan.
9.
This is already a local issue. The Rotherham NHS Foundation Trust
is using its Federated Data Platform instance for outpatient data
quality and patient waiting list validation and is progressing
further use of the platform.
10. Rotherham
Doncaster and South Humber NHS Foundation Trust has confirmed that
its current use of Palantir is limited to non-patient data, with a
separate governance process required before any
expansion.
11. NHS South
Yorkshire Integrated Care Board has signed up to the Federated Data
Platform but stated that, as of June 2026, none of the data
collected within the ICB was flowing into the platform.
12. The National Data
Guardian has reported that more than three million people have
exercised the National Data Opt-out and has warned that uncertainty
or misunderstanding about how health information is used can
undermine public trust. A further loss of confidence could lead
more people to object to the use of their information, making NHS
data less complete and potentially worsening inequalities in health
planning and outcomes.
Believes that:
13. People should not
have to choose between receiving healthcare and trusting what will
happen to the personal information they provide.
14. The issue is not simply that Palantir is a foreign company, The concern is the growing strategic dependence of essential British public services on a private overseas corporation whose ownership, corporate priorities and principal legal jurisdiction sit outside UK democratic control.
15. The most sensitive
NHS and Council information should be managed through systems that
are publicly accountable, transparent, independently scrutinised
and subject to meaningful democratic control.
16. Contractual data
safeguards are necessary but safeguards alone do not answer
legitimate concerns about the suitability, values and wider
activities of a company entrusted with operating critical public
infrastructure.
17. Decisions about
NHS data infrastructure should take account of ethical conduct,
human rights, public confidence, data protection, national
resilience, value for money and the risk of becoming technically or
contractually dependent on one supplier.
18. Public money
allocated to the Federated Data Platform would be better invested
in developing sustainable NHS digital expertise and publicly
accountable UK based infrastructure.
19. Rotherham Council holds highly sensitive information relating to children, adult social care, safeguarding, housing, benefits, employment and vulnerable residents. The Council should apply the same high standards to its own data and should not knowingly allow Palantir technology to process Council held information.
Resolves to:
20. Call on the
Government to exercise the February 2027 break clause in NHS
England’s Federated Data Platform contract and publish a
fully costed and clinically safe plan to transition to an NHS owned
and operated solution or to a transparent UK owned and UK based
alternative.
21. Call on The
Rotherham NHS Foundation Trust and Rotherham Doncaster and South
Humber NHS Foundation Trust to:
- pause any further rollout or expansion of Palantir technology;
- add no new patient datasets, functions or purposes to the platform while the national contract remains under review;
-
publish the relevant Data Protection Impact Assessments and
equality assessments, and
22. Call on NHS South
Yorkshire Integrated Care Board not to begin transferring ICB held
information into the Federated Data Platform and to support the
development of a publicly accountable alternative.
23. Request the
Overview and Scrutiny Management Board to consider adding to its
work programme a referral to the Health Select Commission to
examine:
- the present and proposed use of Palantir technology by local NHS organisations;
- which patient and non-patient datasets are being processed;
- the effect on patient confidence, data objections and the National Data Opt-out;
- the equality implications, particularly for minority communities and groups.
- alternative systems and the potential costs and risks of withdrawal;
- and how Rotherham residents will be consulted before any significant expansion of its use.
24. Council to seek appropriate legal and procurement advice, to
adopt a formal policy that Rotherham Metropolitan Borough Council
will not knowingly procure, commission, license, deploy or permit
Palantir technology to process Council-held information,
either:
- Directly;
- through a principal contractor or subcontractor;
- through partnerships in which the Council is responsible for,
or jointly controls, the information.
This policy
should apply to Palantir Technologies, companies within the
Palantir corporate group and products or services operating on
Palantir platforms.
24. Council to send a
copy of this motion to:
- the Secretary of State for Health and Social Care;
- the Chief Executive of NHS England;
- the Chair and Chief Executive of NHS South Yorkshire Integrated Care Board;
- the Chair and Chief Executive of The Rotherham NHS Foundation Trust;
- the Chair and Chief Executive of Rotherham Doncaster and South Humber NHS Foundation Trust;
- Rotherham Local Medical Committee;
- the British Medical Association;
- all Members of Parliament representing the Rotherham borough.
On being put to the vote, the motion was carried.
Councillor A Carter declared a personal interest in this item as he was a member of the British Medical Association. He remained in the Chamber and voted on the item.
Supporting documents: